Psychiatric medication management for West Palm Beach — residential-level optimization, 28 minutes away.

West Palm Beach sits 28 minutes down I-95 from RECO Immersive's Delray Beach campus — the nearest residential program south of Okeechobee where psychiatric medication management is continuous rather than appointment-based. Lithium and valproate levels are drawn on a medically driven cadence, side effects are addressed at the next med pass rather than the next month, and the discharge plan hands off cleanly to the RECO Health outpatient team or a home-community psychiatrist. For adults whose outpatient trials have plateaued, that observation window is often what makes the next regimen actually work.

West Palm Beach sits 18 miles north of RECO Immersive’s Delray Beach campus — a 28-minute drive down I-95 or Federal Highway outside of rush. For adults in El Cid, Flamingo Park, Northwood Hills, SoSo, or downtown WPB whose depression, bipolar disorder, PTSD, or treatment-resistant anxiety has stalled at the outpatient level, residential care in Delray is the nearest specialist-level option south of Okeechobee Boulevard. Psychiatric medication management inside the residential program is structured differently than a monthly med check — it is a continuous clinical presence built to accelerate the optimization that outpatient prescribing cannot match on speed or precision.

What observed adherence and daily monitoring change

In outpatient psychiatry, whether a client actually took lithium at 8 a.m. or held a scheduled dose of quetiapine is a matter of self-report — supplemented by pill counts, plasma levels weeks later, and clinical impression at the next visit. In residential care, adherence is observed at each administration. That distinction matters most for medications with a narrow therapeutic window (lithium 0.6–1.2 mEq/L, valproate 50–125 mcg/mL), where a missed dose or off-label timing invalidates the level draw and the entire dose-adjustment logic that follows.

The same logic governs side-effect management. Akathisia from aripiprazole, sedation from mirtazapine, GI distress during an SSRI titration, or the fine tremor that precedes a lithium level running high — these surface within hours in residential and get addressed at the next round, not two weeks later after the client has already self-discontinued the medication and called it a failed trial. A significant portion of what gets labeled treatment resistance in outpatient care is, on closer inspection, undocumented nonadherence and prematurely terminated trials. The residential setting removes both variables from the equation.

Comprehensive lab monitoring during the residential stay

Admission includes baseline labs — CBC, CMP, TSH with reflex, B12 and folate, vitamin D, fasting lipid panel, HbA1c, urine drug screen, and urine pregnancy where indicated. For clients admitted with a working diagnosis of bipolar disorder or a mood disorder that hasn’t been fully worked up, this baseline often surfaces subclinical thyroid disease, B12 deficiency, or metabolic derangement that has been driving symptoms independently of the psychiatric picture.

Ongoing monitoring is medication-anchored rather than calendar-anchored. Lithium levels are drawn 12 hours post-dose during titration, weekly until stable. Valproate follows a similar cadence. Atypical antipsychotic exposure — olanzapine, quetiapine, aripiprazole — triggers metabolic monitoring at admission and discharge, with weight and fasting glucose captured. EKG is obtained where cardiovascular risk or a QTc-prolonging combination warrants. A client whose lithium level comes back at 1.4 on Tuesday morning gets a dose adjustment Tuesday afternoon and a repeat level within the week — not at the next available outpatient appointment three weeks out.

Coordination with concurrent interventional treatment

RECO Immersive is embedded within the broader RECO Health ecosystem, which includes rTMS and ketamine and esketamine programs on the same campus. For residential clients pursuing concurrent interventional care — an rTMS course at 3,000 pulses per session, 120% of motor threshold, over 30 to 36 sessions, or a Spravato induction on the label-mandated schedule — the medication regimen is coordinated with the interventional plan by the same psychiatric team.

That coordination has concrete implications. Benzodiazepines are known to attenuate TMS response and are minimized where clinically feasible during the acute course. Ketamine dosing is timed around other psychotropic exposures with attention to serotonergic load and blood pressure. Antidepressant adherence during a TMS course is observed rather than assumed, and interventional gains are integrated into the ongoing pharmacology plan rather than reported back to a separate outpatient prescriber weeks later. Integrated psychiatric medication management is how the residential and interventional tracks stay legible to each other.

What to expect during the first psychiatric evaluation

The initial psychiatric evaluation occurs within 24 hours of admission and runs 60 to 90 minutes. It captures full psychiatric history, prior medication trials with response and side-effect timelines, family psychiatric history, substance use timeline scored against ASAM Criteria dimensions where relevant, and standardized symptom capture — PHQ-9 for depression, GAD-7 for anxiety, PCL-5 for suspected PTSD, MDQ where a bipolar spectrum question is open, YBOCS where OCD is on the differential, and ASRS for adult ADHD.

Where alcohol or benzodiazepine dependence is part of the presentation, CIWA-Ar scoring drives withdrawal management; COWS drives opioid withdrawal protocols including buprenorphine induction. Non-substance psychotropics are reconciled against the admission list — nothing is stopped abruptly without a taper plan except where the pharmacology demands it. Family contact, with the client’s written consent, typically happens in the first 48 to 72 hours to fill in the collateral history that clients under acute symptom load often cannot provide accurately.

The medication plan the client leaves with

Discharge from RECO Immersive includes a documented medication plan: current regimen with clinical rationale, next-step contingencies if a given agent loses response, and a monitoring schedule for the outpatient prescriber. Levels drawn in the last week of stay — lithium, valproate, metabolic parameters at discharge against admission — are included in the handoff packet. Recommendations for continued lab monitoring, whether that’s a thyroid panel at three months on lithium or an HbA1c check at six months on an atypical, are stated with intervals rather than left as a general suggestion.

The client leaves able to articulate why they are on what they are on, what to watch for, and what the next outpatient visit should focus on. That handoff clarity — to the RECO Health outpatient team or to a home-community psychiatrist in Palm Beach County — is what determines whether the pharmacology gains of a residential stay hold in outpatient care or degrade back toward baseline over the following six months.

Insurance and admissions from West Palm Beach

RECO Immersive works with most major commercial plans, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Admissions from West Palm Beach are handled directly — verification of benefits, single-case agreements where applicable, and same-day intake in most cases. From downtown WPB, El Cid, or SoSo, the drive is 28 minutes on I-95; from Northwood Hills, closer to 35. Transport can be coordinated when acute symptomatology or active withdrawal makes self-transport clinically inappropriate.

Serving residents of: El Cid, Flamingo Park, Northwood Hills, SoSo, Downtown WPB.